Biodelivery Sciences International Stock, NASDAQ:BDSI
4131 Parklake Avenue, Suite 225, Raleigh, North Carolina 27612
United States of America
Number of Employees: 176
BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.